LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease

被引:107
作者
Harrison, SM
Reavill, C
Brown, G
Brown, JT
Cluderay, JE
Crook, B
Davies, CH
Dawson, LA
Grau, E
Heidbreder, C
Hemmati, P
Hervieu, G
Howarth, A
Hughes, ZA
Hunter, AJ
Latcham, J
Pickering, S
Pugh, P
Rogers, DC
Shilliam, CS
Maycox, PR
机构
[1] GlaxoSmithKline, Psychiat CEDD, Schizophrenia & Bipolar Disorder Res, Harlow CM19 5AW, Essex, England
[2] GlaxoSmithKline, Neurol & Gastrointesinal Ctr Excellence Drug Disc, Harlow CM19 5AW, Essex, England
[3] GlaxoSmithKline, Lab Anim Sci, Harlow CM19 5AW, Essex, England
[4] GlaxoSmithKline, Comparat Genom, Harlow CM19 5AW, Essex, England
[5] GlaxoSmithKline, Resp Inflammat Resp Pathogens Ctr Excellence Drug, Stevenage, Herts, England
关键词
D O I
10.1016/j.mcn.2003.09.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Several psychiatric diseases, including schizophrenia, are thought to have a developmental aetiology, but to date no clear link has been made between psychiatric disease and a specific developmental process. LPA(1) is a G(i)-coupled seven transmembrane receptor with high affinity for lysophosphatidic acid. Although LPA, is expressed in several peripheral tissues, in the nervous system it shows relatively restricted temporal expression to neuroepithelia during CNS development and to myelinating glia in the adult. We report the detailed neurological and behavioural analysis of mice homozygous for a targeted deletion at the lpa(1) locus. Our observations reveal a marked deficit in prepulse inhibition, widespread changes in the levels and turnover of the neurotransmitter 5-HT, a brain region-specific alteration in levels of amino acids, and a craniofacial dysmorphism in these mice. We suggest that the loss of LPA(1) receptor generates defects resembling those found in psychiatric disease. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:1170 / 1179
页数:10
相关论文
共 41 条
[1]   A rat G protein-coupled receptor selectively expressed in myelin-forming cells [J].
Allard, J ;
Barrón, S ;
Diaz, J ;
Lubetzki, C ;
Zalc, B ;
Schwartz, JC ;
Sokoloff, P .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (03) :1045-1053
[2]   Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid [J].
An, SZ ;
Dickens, MA ;
Bleu, T ;
Hallmark, OG ;
Goetzl, EJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 231 (03) :619-622
[3]  
ASBERG M, 1976, ARCH GEN PSYCHIAT, V33, P1193
[4]  
BICKERDIKE MJ, 1993, BEHAV PHARMACOL, V4, P231
[5]   Schizophrenia as a neurodevelopmental disorder [J].
Bilder, RM .
CURRENT OPINION IN PSYCHIATRY, 2001, 14 (01) :9-15
[6]  
BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206
[7]   Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia [J].
Callicott, JH ;
Bertolino, A ;
Egan, MF ;
Mattay, VS ;
Langheim, FJP ;
Weinberger, DR .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (10) :1646-1651
[8]   Requirement for the IpA1 lysophosphatidic acid receptor gene in normal suckling behavior [J].
Contos, JJA ;
Fukushima, N ;
Weiner, JA ;
Kaushal, D ;
Chun, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) :13384-13389
[9]   PAIRED-PULSE DEPRESSION OF MONOSYNAPTIC GABA-MEDIATED INHIBITORY POSTSYNAPTIC RESPONSES IN RAT HIPPOCAMPUS [J].
DAVIES, CH ;
DAVIES, SN ;
COLLINGRIDGE, GL .
JOURNAL OF PHYSIOLOGY-LONDON, 1990, 424 :513-531
[10]   Improved method for the measurement of glutamate and aspartate using capillary electrophoresis with laser induced fluorescence detection and its application to brain microdialysis [J].
Dawson, LA ;
Stow, JM ;
Palmer, AM .
JOURNAL OF CHROMATOGRAPHY B, 1997, 694 (02) :455-460